Form 8-K ZIMMER BIOMET HOLDINGS, For: Aug 04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Zimmer Biomet (ZBH) PT Raised to $150 at Oppenheimer Due to MyMobility App Digital Health
August 5, 2020 8:38 AM EDTOppenheimer analyst Steven Lichtman raised the price target on Zimmer Biomet (NYSE: ZBH) to $150.00 (from $138.00) while maintaining a Outperform rating citing COVID-19, solid pull-through, Persona Revision launch, a push into telehealth with the mymobility app, strong demand for ROSA, and low capex... More
